Neogen (NEOG) Amortization of Deferred Charges (2022 - 2026)
Neogen's (NEOG) quarterly Amortization of Deferred Charges came in at $479000.0 in Q1 2026, down 45.57% year-on-year from $880000.0 in Q1 2025, and down 0.62% quarter-over-quarter from $482000.0 in Q4 2025.
Neogen (NEOG) Amortization of Deferred Charges (2022 - 2026) Analysis & Trends
Neogen's Amortization of Deferred Charges history runs 5 years deep, the most recent figure standing at $479000.0 for Q1 2026.
- On a quarterly basis, Amortization of Deferred Charges fell 45.57% year-over-year to $479000.0 in Q1 2026; TTM through Feb 2026 was $5.1 million, a 12.36% increase from a year earlier, with the FY2025 full-year figure at $6.2 million, up 37.23% from the prior year.
- Amortization of Deferred Charges eased to $479000.0 in Q1 2026 per NEOG's latest filing, from $482000.0 in the prior quarter.
- Across five years, Amortization of Deferred Charges topped out at $3.6 million in Q2 2025 and bottomed at $122000.0 in Q4 2022.
- The 5-year median for Amortization of Deferred Charges is $510500.0 (2025), against an average of $800214.3.
- Across the five-year window, Amortization of Deferred Charges jumped 713.92% in 2024 and tumbled 45.57% in 2026, its largest moves.
- Year by year, Amortization of Deferred Charges stood at $122000.0 in 2022, then changed by 0.0% to $122000.0 in 2023, then soared by 604.92% to $860000.0 in 2024, then plunged by 43.95% to $482000.0 in 2025, then retreated by 0.62% to $479000.0 in 2026.
- Per Business Quant, the three latest NEOG Amortization of Deferred Charges figures stand at $479000.0 (Q1 2026), $482000.0 (Q4 2025), and $539000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.47 Bn | 176.17 Bn | 6.27 Bn |
| 2 | Stryker | 129.01 Bn | 126.14 Bn | 3.81 Bn |
| 3 | Medtronic | 108.97 Bn | 99.75 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 48.40 Bn | 44.73 Bn | 1.29 Bn |
| 6 | Dexcom | 28.37 Bn | 27.25 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.07 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - |
| 9 | Koninklijke Philips | 25.46 Bn | 22.33 Bn | 2.07 Bn |
| 10 | Neogen | 2.07 Bn | 1.91 Bn | 99.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 479,000.00 |
| Feb 28, 2026 | 479,000.00 |
| Nov 30, 2025 | 482,000.00 |
| Nov 30, 2025 | 482,000.00 |
| Aug 31, 2025 | 539,000.00 |
| Aug 31, 2025 | 539,000.00 |
| May 31, 2025 | 3.59 Mn |
| May 31, 2025 | 3.59 Mn |
| Feb 28, 2025 | 880,000.00 |
| Feb 28, 2025 | 880,000.00 |
| Nov 30, 2024 | 860,000.00 |
| Nov 30, 2024 | 860,000.00 |
| Aug 31, 2024 | 860,000.00 |
| Aug 31, 2024 | 860,000.00 |
| May 31, 2024 | 1.93 Mn |
| May 31, 2024 | 1.93 Mn |
| Feb 29, 2024 | 122,000.00 |
| Feb 29, 2024 | 122,000.00 |
| Nov 30, 2023 | 122,000.00 |
| Nov 30, 2023 | 122,000.00 |